Frank Haluska, SVP, Clinical R&D, CMO at ARIAD PHARMACEUTICALS INC (ARIA), sold 2,400 shares at $19.46 ($47K) on 2013-03-22, disclosed to the SEC on 2013-03-22.
Open-market sale of $47k ARIA by SVP, Clinical R&D, CMO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| ARIA | SELL | 2016-02-03 | $155K | — | Filing → |
| ARIA | SELL | 2015-09-28 | $36K | — | Filing → |
| ARIA | SELL | 2015-07-16 | $38K | — | Filing → |